Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01940276
Title Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Duke University
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Birmingham VA Medical Center Birmingham Alabama 35233 United States Details
Tulane Cancer Center New Orleans Louisiana 70112 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Maria Parham Medical Center Henderson North Carolina 27536 United States Details
Scotland Memorial Hospital Laurinburg North Carolina 28352 United States Details
Southeastern Regional Lumberton North Carolina 28359 United States Details
Duke Raleigh Hospital Raleigh North Carolina 27609 United States Details
W. G. 'Bill' Hefner VA Medical Center Salisbury North Carolina 28144 United States Details
Johnston Memorial Hospital Smithfield North Carolina 27577 United States Details
Wake Forest University Winston-Salem North Carolina 27157 United States Details
Spartanburg Regional Spartanburg South Carolina 29303 United States Details
Virginia Oncology Associates Hampton Virginia 23666 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field